Taylor Morrison Home
TMHC
NVIDIA
NVDA
D.R. Horton
DHI
Adobe
ADBE
Meritage Homes
MTH
US Stock MarketDetailed Quotes
INKT MiNK Therapeutics
- 8.410
- +0.490+6.19%
Close Mar 20 16:00 ET
- 7.740
- -0.670-7.97%
Post 16:49 ET
33.36MMarket Cap-2.94P/E (TTM)
8.690High7.923Low19.47KVolume8.638Open7.920Pre Close159.69KTurnover1.92%Turnover RatioLossP/E (Static)3.97MShares19.00052wk High-1.70P/B8.54MFloat Cap4.56052wk Low--Dividend TTM1.02MShs Float221.550Historical High--Div YieldTTM9.68%Amplitude4.560Historical Low8.200Avg Price1Lot Size
MiNK Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 39.38%-9.56M | 43.09%-1.73M | 28.85%-2.99M | 44.82%-2.29M | 41.78%-2.54M | 16.45%-15.76M | 31.48%-3.04M | 25.03%-4.21M | 10.25%-4.15M | -4.05%-4.37M |
| Net income from continuing operations | 51.98%-10.78M | 54.88%-2.46M | 64.69%-1.81M | 56.40%-2.7M | 32.94%-3.81M | 19.77%-22.46M | 29.75%-5.46M | 19.20%-5.12M | -1.38%-6.2M | 26.89%-5.69M |
| Operating gains losses | -639.77%-1.97M | ---1.79M | --0 | ---- | ---- | 90.44%-266.78K | ---- | ---- | ---- | ---- |
| Depreciation and amortization | 5.29%215.44K | 0.55%53.87K | 17.18%62.64K | -13.11%45.1K | 17.83%53.83K | 68.06%204.62K | 41.23%53.57K | 88.02%53.45K | 83.36%51.91K | 68.73%45.69K |
| Other non cash items | --717.49K | --2.1M | ---1.58M | --194.14K | --4.44K | ---- | ---- | ---- | ---- | ---- |
| Change In working capital | -84.13%459.73K | -101.69%-21.45K | 29.91%-60K | -105.84%-79.63K | 75.96%620.81K | -66.95%2.9M | -51.88%1.27M | -1.38%-85.6K | -60.50%1.36M | -87.25%352.81K |
| -Change in prepaid assets | -179.06%-194.17K | 0.66%-11.01K | -161.19%-136.77K | -192.78%-40.05K | 36.57%-6.35K | 182.71%245.59K | 69.00%-11.08K | 241.01%223.52K | -45.56%43.16K | 94.50%-10.01K |
| -Change in payables and accrued expense | -1,565.31%-1.58M | -146.02%-410.15K | 48.23%-501.69K | -197.12%-564.37K | 74.73%-99.99K | -98.23%107.57K | -63.36%891.2K | -300.26%-969.15K | -56.48%581.12K | -121.57%-395.61K |
| -Change in other working capital | -12.34%2.23M | 3.21%399.7K | -12.36%578.46K | -28.92%524.78K | -4.12%727.14K | -14.57%2.54M | 63.49%387.27K | 261.04%660.03K | -63.72%738.26K | -32.05%758.42K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 39.38%-9.56M | 43.09%-1.73M | 28.85%-2.99M | 44.82%-2.29M | 41.78%-2.54M | 16.45%-15.76M | 31.48%-3.04M | 25.03%-4.21M | 10.25%-4.15M | -4.05%-4.37M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 0 | 0 | 0 | 70.58%-73.56K | 0 | 61.46%-23.04K | 40.69%-37.02K | -13.5K |
| Net PPE purchase and sale | --0 | --0 | --0 | --0 | --0 | 70.58%-73.56K | --0 | 61.46%-23.04K | 40.69%-37.02K | ---13.5K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | --0 | --0 | --0 | 70.58%-73.56K | --0 | 61.46%-23.04K | 40.69%-37.02K | ---13.5K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 2,757.34%10.82M | -50.00%-3 | 130.52%6.81K | 7,770.33%5.81M | 1,597.17%5.01M | -161.68%-407.17K | -101.80%-2 | 497.57%2.95K | 51.75%-75.7K | -48,637.74%-334.43K |
| Net issuance payments of debt | --5M | --0 | --0 | --0 | --5M | --0 | --0 | --0 | --0 | --0 |
| Net common stock issuance | 1,314.31%5.8M | --0 | --0 | 6,035.45%5.8M | --0 | -203.85%-477.64K | ---2 | --2 | 37.84%-97.72K | ---379.92K |
| Proceeds from stock option exercised by employees | -71.64%19.99K | ---3 | 130.68%6.81K | -71.44%6.29K | -84.84%6.9K | 4,317.93%70.47K | --0 | 497.17%2.95K | 7,215.61%22.02K | 6,503.19%45.5K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 2,757.34%10.82M | -50.00%-3 | 130.52%6.81K | 7,770.33%5.81M | 1,597.17%5.01M | -161.68%-407.17K | -101.80%-2 | 497.57%2.95K | 51.75%-75.7K | -48,637.74%-334.43K |
| Net cash flow | ||||||||||
| Beginning cash position | -82.85%3.37M | -1.10%6.33M | -12.32%9.31M | -60.94%5.82M | -82.85%3.37M | -49.51%19.64M | -73.51%6.4M | -64.41%10.62M | -57.07%14.89M | -49.51%19.64M |
| Current changes in cash | 107.78%1.26M | 43.09%-1.73M | 29.35%-2.99M | 182.45%3.52M | 152.28%2.46M | 15.72%-16.24M | 33.40%-3.04M | 25.46%-4.23M | 11.99%-4.26M | -12.36%-4.71M |
| Effect of exchange rate changes | -116.63%-54.7K | -646.04%-23.53K | -54.48%2.69K | -210.58%-19.02K | 49.43%-14.84K | -230.26%-25.25K | -87.82%4.31K | 141.32%5.91K | -313.01%-6.12K | -539.77%-29.34K |
| End cash Position | 35.93%4.58M | 35.93%4.58M | -1.10%6.33M | -12.32%9.31M | -60.94%5.82M | -82.85%3.37M | -82.85%3.37M | -73.51%6.4M | -64.41%10.62M | -57.07%14.89M |
| Free cash flow | 39.66%-9.56M | 43.09%-1.73M | 29.23%-2.99M | 45.30%-2.29M | 41.96%-2.54M | 17.16%-15.84M | 33.40%-3.04M | 25.42%-4.23M | 10.66%-4.19M | -4.37%-4.38M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.